51985-35-4Relevant academic research and scientific papers
DIBENZENE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS
-
Page/Page column 14, (2009/04/24)
The invention is directed to a compound of formula (I) Having VDCC blocking activity. These compounds are useful for the treatment of a series of human diseases and conditions, especially cognitive or neurodegenerative diseases or conditions.
PHENOXYALKANOIC ACID COMPOUND
-
Page/Page column 41, (2008/06/13)
The present invention provides a compound represented by the formula: wherein each symbol is as defined in the specification. Since the compound of the present invention has superior hypoglycemic action and superior hypolipidemic action, it is useful as an agent for the prophylaxis or treatment of diabetes, hyperlipidemia, impaired glucose tolerance and the like.
Dibenzene derivatives as calcium channel blockers
-
Page/Page column 10, (2010/11/27)
The invention is directed to a compound of formula (I) Having VDCC blocking activity. These compounds are useful for the treatment of a series of human diseases and conditions, especially cognitive or neurodegenerative diseases or conditions.
